Update on the Treatment of Alzheimer's Disease: Aducanumab Recorded Session

In this session, you will gain an understanding of Alzheimer’s Disease and current treatments. Clinical trials and studies will be discussed to gain knowledge on the successes/fails of different treatment options.

If you attended Update on the Treatment of Alzheimer's Disease: Aducanumab on February 24, 2022, you will not be able to claim credit again for this course. However, you are welcome to still watch the content.

Target Audience

This course is intended for all physicians including generalists, neurologists, intensivists, radiologists, and pathologists, RN's, PA's, NP's, RTT's, and various other members of the health care team

Learning Objectives

At the end of this session, learners should be able to:

  1. Identify current treatments for patients with Alzheimer’s Disease
  2. Apply knowledge from clinical trials and studies into practice
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
    Aurora Health Care is accredited by the Wisconsin Medical Society to provide continuing medical education for physicians. Aurora Health Care designates this activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
  • 1.00 Attendance
    Attendance Credit
    • 1.00 Approved AMA PRA Category 1 Credit™
Course opens: 
02/24/2022
Course expires: 
12/31/2023
Cost:
$0.00
Rating: 
0

Faculty

Darren Gitelman, MD; Advocate Aurora Health
Eric Maas, MD; Advocate Aurora Health
Paul Vilar, MSN, RN, SCRN; Advocate Aurora Health
Rachael Wade, MHA; Advocate Aurora Health
Amy Campbell, Executive Assistant; Advocate Aurora Health

 

Disclosure

The following faculty speakers and/or planning committee members have disclosed the following:

Faculty Name

Name of Ineligible Companies

Nature of Relationship

Darren Gitelman, MD

-Biogen
-Eisai; Lilly; Abbvie
-Novartis

-Research Funding, Speaking fees
-Research Funding
-Consultant

The other planner(s) and speaker(s) have indicated that there are no relevant financial relationships with any ineligible companies to disclose. Conflict of interest have been identified and mitigated prior to the activity.

Accreditation Statement
Advocate Aurora Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement
Advocate Aurora Health designates this enduring material for a maximum of 1.0 AMA PRA Category 1 credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
    Aurora Health Care is accredited by the Wisconsin Medical Society to provide continuing medical education for physicians. Aurora Health Care designates this activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
  • 1.00 Attendance
    Attendance Credit
    • 1.00 Approved AMA PRA Category 1 Credit™

Price

Cost:
$0.00
Please login or register to take this course.

 

If you attended Update on the Treatment of Alzheimer's Disease: Aducanumab on February 24, 2022, you will not be able to claim credit again for this course. However, you are welcome to still watch the content.

Click “Take Course” to register for this program.  

Contact the Advocate Aurora Health CME Office at cme@aah.org if you have any questions or need assistance.